Uma revisão de literatura das terapias farmacológicas e não farmacológicas no tratamento da demência
DOI:
https://doi.org/10.18378/rebes.v14i3.10659Abstract
The present article addresses dementia, a neurodegenerative syndrome characterized by the progressive deterioration of cognitive functions, which affects millions of people worldwide, especially in aging populations. The increasing prevalence of dementia, associated with the rising life expectancy, poses significant public health challenges, requiring therapeutic approaches to improve the quality of life for patients. In light of this, this study aims to analyze the pharmacological and non-pharmacological therapies used in the treatment of dementia, evaluating their efficacy, limitations, and benefits, as well as discussing the importance of integrative approaches that combine both therapeutic modalities. The analysis of pharmacological therapies includes cholinesterase inhibitors (donepezil, rivastigmine, and galantamine) and NMDA receptor antagonists (memantine), as well as adjuvant therapies (antidepressants, antipsychotics, and anticonvulsants). Although these medications offer improvements in cognitive and behavioral symptoms, they present limitations in terms of efficacy and side effects. In conjunction, non-pharmacological therapies, such as psychosocial interventions (cognitive and behavioral therapy, reminiscence therapy, validation therapy, cognitive stimulation), occupational interventions (recreational activities, occupational therapy), physical interventions (physical exercise, physiotherapy, movement therapy), and alternative interventions (music therapy, art therapy, aromatherapy), demonstrate benefits in the patients' quality of life, addressing the cognitive, emotional, and social aspects of dementia. The results indicate that the integration of pharmacological and non-pharmacological therapies provides a more effective approach to managing dementia. Thus, it is concluded that a personalized and multidisciplinary treatment, adapted to the individual needs of patients, is indispensable for optimizing therapeutic outcomes and improving the quality of life for those affected by the condition.
Downloads
References
ABRAHA, I. et al. Systematic review of systematic reviews of non-pharmacological interventions to treat behavioural disturbances in older patients with dementia. The SENATOR-OnTop series. BMJ open, v. 7, n. 3, p. e012759, 2017.
BASTIDA, J. D. et al. La depresión: un predictor de demencia. Revista espanola de geriatria y gerontologia, v. 51, n. 2, p. 112-118, 2016.
BESSEY, L. J.; WALASZEK, Art. Management of behavioral and psychological symptoms of dementia. Current psychiatry reports, v. 21, p. 1-11, 2019.
CABRERA, E. et al. Non-pharmacological interventions as a best practice strategy in people with dementia living in nursing homes. A systematic review. European Geriatric Medicine, v. 6, n. 2, p. 134-150, 2015.
CERVANTES, C. Moreno et al. Factores asociados a la demencia mixta en comparación con demencia tipo Alzheimer en adultos mayores mexicanos. Neurología, v. 32, n. 5, p. 309-315, 2017.
CHALFONT, G.; MILLIGAN, C.; SIMPSON, J. A mixed methods systematic review of multimodal non-pharmacological interventions to improve cognition for people with dementia. Dementia, v. 19, n. 4, p. 1086-1130, 2020.
CUSTODIO, N. et al. Mixed dementia: A review of the evidence. Dementia & neuropsychologia, v. 11, p. 364-370, 2017.
CUSTODIO, N.; MONTESINOS, R.; ALARCÓN, J. O. Evolución histórica del concepto y criterios actuales para el diagnóstico de demencia. Revista de Neuro-Psiquiatría, v. 81, n. 4, p. 235-249, 2018.
D’ONOFRIO, G. et al. Non-pharmacological approaches in the treatment of dementia. Update on dementia, p. 477-491, 2016.
DENING, T.; SANDILYAN, M. B. Dementia: definitions and types. Nursing Standard (2014+), v. 29, n. 37, p. 37, 2015.
DYER, S. M. et al. An overview of systematic reviews of pharmacological and non-pharmacological interventions for the treatment of behavioral and psychological symptoms of dementia. International psychogeriatrics, v. 30, n. 3, p. 295-309, 2018.
FERENCZ, B.; GERRITSEN, L. Genetics and underlying pathology of dementia. Neuropsychology review, v. 25, p. 113-124, 2015.
FINK, H. A. et al. Pharmacologic interventions to prevent cognitive decline, mild cognitive impairment, and clinical Alzheimer-type dementia: a systematic review. Annals of internal medicine, v. 168, n. 1, p. 39-51, 2018.
HERSHEY, L. A.; COLEMAN-JACKSON, Rhonda. Pharmacological management of dementia with Lewy bodies. Drugs & Aging, v. 36, p. 309-319, 2019.
IRAZOKI, E. et al. Eficacia de la terapia de reminiscencia grupal en personas con demencia. Revisión sistemática y metaanálisis. Rev Neurol, v. 65, n. 10, p. 447-456, 2017.
KHAN, A. et al. Update on vascular dementia. Journal of geriatric psychiatry and neurology, v. 29, n. 5, p. 281-301, 2016.
MAGIERSKI, R. et al. Pharmacotherapy of behavioral and psychological symptoms of dementia: state of the art and future progress. Frontiers in pharmacology, v. 11, p. 1168, 2020.
MEDEIROS, A. R. et al. A relação entre gênero e demência em idosos no Brasil. Revista Educação em Saúde, v. 8, p. 24-28, 2020.
MENDES, G. A. et al. Apoio a cuidadores familiares de idosos com demência. Brazilian Journal of Development, v. 6, n. 10, p. 76828-76839, 2020.
MEYER, C.; O’KEEFE, F. Non-pharmacological interventions for people with dementia: A review of reviews. Dementia, v. 19, n. 6, p. 1927-1954, 2020.
OLLEY, R.; MORALES, A. Systematic review of evidence underpinning non-pharmacological therapies in dementia. Australian Health Review, v. 42, n. 4, p. 361-369, 2017.
PACKER, R.; BEN SHLOMO, Y.; WHITING, P. Can non-pharmacological interventions reduce hospital admissions in people with dementia? A systematic review. PLoS One, v. 14, n. 10, p. e0223717, 2019.
PHAN, S. V. et al. Neuropsychiatric symptoms in dementia: considerations for pharmacotherapy in the USA. Drugs in R&D, v. 19, p. 93-115, 2019.
SANTOS, C. de S. dos; BESSA, T. A. de; XAVIER, A. J. Fatores associados à demência em idosos. Ciência & Saúde Coletiva, v. 25, n. 2, p. 603-611, 2020.
SARAIVA, M. G et al. Demencia por corpos de lewy e alzheimer: diferença no diagnóstico. Saúde Coletiva (Barueri), v. 13, n. 87, p. 13001-13012, 2023.
SHEEN, Y.; SHEU, W. H. Association between hypoglycemia and dementia in patients with type 2 diabetes. Diabetes Research and Clinical Practice, v. 116, p. 279-287, 2016.
STINTON, C. et al. Pharmacological management of Lewy body dementia: a systematic review and meta-analysis. American Journal of Psychiatry, v. 172, n. 8, p. 731-742, 2015.
Downloads
Published
Versions
- 2024-07-31 (3)
- 2024-07-22 (2)
- 2024-07-22 (1)
How to Cite
Issue
Section
License
Copyright (c) 2024 Adriane Barbosa de Sousa , Gabriela Oliveira Vilela , Patrícia Leonardo Magalhães dos Santos , Vinicius Vieria Queiroga , Joyce Ursula Thomaz Oliveira , Jamily Lucena Salviano , Tainah Guerra Pereira, Igor Freitas Moura
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Termo de cess